| Molecular portraits of human breast tumours CM Perou, T Sørlie, MB Eisen, M Van De Rijn, SS Jeffrey, CA Rees, ... nature 406 (6797), 747-752, 2000 | 20098 | 2000 |
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications T Sørlie, CM Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, ... Proceedings of the National Academy of Sciences 98 (19), 10869-10874, 2001 | 17295* | 2001 |
| Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors JR Pollack, T Sørlie, CM Perou, CA Rees, SS Jeffrey, PE Lonning, ... Proceedings of the National Academy of Sciences 99 (20), 12963-12968, 2002 | 1475 | 2002 |
| Database of p53 gene somatic mutations in human tumors and cell lines. M Hollstein, K Rice, MS Greenblatt, T Soussi, R Fuchs, T Sørlie, E Hovig, ... Nucleic acids research 22 (17), 3551, 1994 | 1358 | 1994 |
| Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival HY Chang, DSA Nuyten, JB Sneddon, T Hastie, R Tibshirani, T Sørlie, ... Proceedings of the national academy of sciences 102 (10), 3738-3743, 2005 | 1141 | 2005 |
| Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer A Bergamaschi, YH Kim, P Wang, T Sørlie, T Hernandez‐Boussard, ... Genes, Chromosomes and Cancer 45 (11), 1033-1040, 2006 | 613 | 2006 |
| Molecular portraits of breast cancer: tumour subtypes as distinct disease entities T Sørlie European journal of cancer 40 (18), 2667-2675, 2004 | 532 | 2004 |
| Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms T Sørlie, Y Wang, C Xiao, H Johnsen, B Naume, RR Samaha, ... BMC genomics 7, 1-15, 2006 | 517 | 2006 |
| Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome A Bergamaschi, E Tagliabue, T Sørlie, B Naume, T Triulzi, R Orlandi, ... The Journal of pathology 214 (3), 357-367, 2008 | 469 | 2008 |
| Gene expression patterns in ovarian carcinomas ME Schaner, DT Ross, G Ciaravino, T Sørlie, O Troyanskaya, M Diehn, ... Molecular biology of the cell 14 (11), 4376-4386, 2003 | 445 | 2003 |
| Triple-negative breast cancer: present challenges and new perspectives F Podo, LMC Buydens, H Degani, R Hilhorst, E Klipp, IS Gribbestad, ... Molecular oncology 4 (3), 209-229, 2010 | 398 | 2010 |
| Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression IO Potapenko, VD Haakensen, T Lüders, Å Helland, I Bukholm, T Sørlie, ... Molecular oncology 4 (2), 98-118, 2010 | 216 | 2010 |
| Cell-type-specific responses to chemotherapeutics in breast cancer MA Troester, KA Hoadley, T Sørlie, BS Herbert, AL Børresen-Dale, ... Cancer research 64 (12), 4218-4226, 2004 | 208 | 2004 |
| Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer AA Muggerud, JA Rønneberg, F Wärnberg, J Botling, F Busato, ... Breast Cancer Research 12, 1-10, 2010 | 203 | 2010 |
| Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling VN Kristensen, CJ Vaske, J Ursini-Siegel, P Van Loo, SH Nordgard, ... Proceedings of the National Academy of Sciences 109 (8), 2802-2807, 2012 | 202 | 2012 |
| Genomic architecture characterizes tumor progression paths and fate in breast cancer patients HG Russnes, HKM Vollan, OC Lingjærde, A Krasnitz, P Lundin, B Naume, ... Science translational medicine 2 (38), 38ra47-38ra47, 2010 | 175 | 2010 |
| Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer T Sørlie, CM Perou, C Fan, S Geisler, T Aas, A Nobel, G Anker, LA Akslen, ... Molecular cancer therapeutics 5 (11), 2914-2918, 2006 | 159 | 2006 |
| An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment X Tekpli, T Lien, AH Røssevold, D Nebdal, E Borgen, HO Ohnstad, ... Nature communications 10 (1), 5499, 2019 | 157 | 2019 |
| Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer B Naume, X Zhao, M Synnestvedt, E Borgen, HG Russnes, OC Lingjærde, ... Molecular oncology 1 (2), 160-171, 2007 | 157 | 2007 |
| Re-definition of claudin-low as a breast cancer phenotype C Fougner, H Bergholtz, JH Norum, T Sørlie Nature communications 11 (1), 1787, 2020 | 153 | 2020 |
